Physicochemical profiling in drug research: A brief survey of the state-of-the-art of experimental techniques

Cellular and Molecular Life Sciences

Volumn 59, Issue 10, 2002, Pages 1681-1689

  Avdeef, A ^a   Testa, B ^b  

^a PION INC   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Distribution; High throughput method; Ionization; Lipophilicity; Permeability; Screening; Solubility

Indexed keywords

4 METHYLBENZOIC ACID; DRUG VEHICLE; LIPOSOME;

ANALYTIC METHOD; ANISOTROPY; ARTIFICIAL MEMBRANE; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG RESEARCH; DRUG SCREENING; DRUG SOLUBILITY; EXPERIMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZATION; LIPID MEMBRANE; LIPOPHILICITY; MASS SPECTROMETRY; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; POTENTIOMETRY; REVIEW; TURBIDIMETRY; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0036809320     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00012496     Document Type: Review

References (59)

1. Lahana R. (1999) How many leads from HTS? Drug Discov. Today 4: 447-448
2. Testa B. (1984) Drugs? Drug research? Advances in drug research? Musings of a medicinal chemist. In: Advances in Drug Research, vol. 13, pp. 1-58, Testa B. (ed.), Academic Press, London
3. Testa B., Waterbeemd H. van de, Folkers G. and Guy R. (eds) (2001) Pharmacokinetic Optimization in Drug Research - Biological, Physicochemical, and Computational Strategies, Wiley-VHCA, Zürich
4. Gaviraghi G., Barnaby R. J. and Pellegatti M. (2001) Pharmacokinetic challenges in lead optimization. In: Pharmacokinetic Optimization in Drug Research - Biological, Physicochemical, and Computational Strategies, pp. 3-14, Testa B., Waterbeemd H. van de, Folkers G. and Guy R. (eds), Wiley-VHCA, Zürich
5. Testa, B. and Soine W. (in press) Principles of drug metabolism. In: Burger's Medicinal Chemistry and Drug Discovery, 6th Ed, Abraham D. J. (ed.), Wiley, New York
6. Amidon G. L., Lennernäs H., Shah V. P. and Crison J. R. (1995) A theoretical basis for a biopharmaceutic drug classification system: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12: 413-420
7. Pagliara A., Reist M., Geinoz S., Carrupt P. A. and Testa B. (1999) Evaluation and prediction of drug permeation. J. Pharm. Pharmacol. 51: 1339-1357
8. Testa B., Crivori P., Reist M. and Carrupt P. A. (2000) The influence of lipophilicity on the pharmacokinetic behavior of drugs: Concepts and examples. Perspect. Drug Discov. Design 19: 179-211
9. Testa B., Caron G., Crivori P., Rey S., Reist M. and Carrupt P. A. (2000) Lipophilicity and related molecular properties as determinants of pharmacokinetic behaviour. Chimia 54: 672-677
10. Waterbeemd H. van de, Smith D. A., Beaumont K. and Walker D. K. (2001) Property-based design: Optimization of drug absorption and pharmacokinetics. J. Med. Chem. 44: 1313-1333
11. Waterbeemd H. van de, Smith D. A., Jones B. C. (2001) Lipophilicity in PK design: Methyl, ethyl, futile. J. Comp.-Aided Mol. Design 15: 273-286
12. Kerns E. H. (2001) High throughput physicochemical profiling for drug discovery. J. Pharm. Sci. 90: 1838-1858
13. Avdeef A. (2001) Physicochemical profiling (solubility, permeability and charge state). Curr. Topics Med. Chem. 1: 277-351
14. a determination of water-insoluble compounds: Validation study in methanol/water mixtures, Int. J. Pharm. 151: 235-248
15. Gampp H., Maeder M., Meyer C. J. and Zuberbühler A. D. (1985) Calculation of equilibrium constants from multiwave-length spectroscopic data. III. Model-free analysis of spectrophotometric and ESR titrations. Talanta 32: 1133-1139
16. Allen R. I., Box K. J., Comer J. E. A., Peake C. and Tam K. Y. (1998) Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs. J. Pharm. Biomed. Anal. 17: 699-712
17. Mitchell R. C., Salter C. J. and Tam K. Y. (1999) Multiwave-length spectrophotometric determination of acid dissociation constants. III. Resolution of multi-protic ionization systems. J. Pharm. Biomed. Anal. 20: 289-295
18. Tam K. Y. and Quéré L. (2001) Multiwavelength spectrophotometric resolution of the micro-equilibria of cetirizine. Anal. Sci. 17: 1203-1208
19. Box K. J., Comer J. E. A., Hosking P., Tam K. Y., Trowbridge L. and Hill A. (2000) Rapid physicochemical profiling as an aid to drug candidate selection. In: High Throughput Screening: The Next Generation, pp. 67-74, Dixon G. K., Major J. S. and Rice M. J. (eds), Bios, Oxford
20. Alibrandi G., Coppolino S., Micali N. and Villari A. (2001) Variable pH kinetics: An easy determination of pH-rate profile. J. Pharm. Sci. 90: 270-274
21. Ishihama Y., Oda Y. and Asakawa N. (1994) Microscale determination of dissociation constants of multivalent pharmaceuticals by capillary electrophoresis. J. Pharm. Sci. 83: 1500-1507
22. a determination of drugs using pressure-assisted capillary electrophoresis with photodiode array detection in drug discovery. J. Pharm. Sci. 91: 933-942
23. El Tayar N., Tsai R. S., Testa B., Carrupt P. A. and Leo A. (1991) Partitioning of solutes in different solvent systems: The contribution of hydrogen-bonding and polarity. J. Pharm. Sci. 80: 590-598
24. Waterbeemd H. van de and Testa B. (1987) The parametrisation of lipophilicity and other structural properties in drug design. Adv. Drug Res. 16: 85-225
25. Carrupt P. A., Testa B. and Galliard P. (1997) Computational approaches to lipophilicity: Methods and applications. Rev. Comput. Chem. 11: 241-315
26. Dyrssen D. (1952) Studies on the extraction of metal complexes. IV. The dissociation constants and partition coefficients of 8-quinolinol (oxine) and n-nitroso-n-phenylhydroxylamine (cup-ferron). Sv. Kem. Tidsks. 64: 213-224
27. Avdeef A. (1996) Assessment of distribution - pH profiles. In: Lipophilicity in Drug Action and Toxicology, pp. 109-139, Pliska V., Testa B. and Waterbeemd H. van de (eds), VCH, Weinheim
28. Reymond F., Chopineaux-Courtois V., Steyaert G., Bouchard G., Carrupt P. A., Testa B. et al. (1999) Ionic partition diagrams of ionisable drugs: pH-lipophilicity profiles, transfer mechanisms and charge effects on solvation. J. Electroanalyt. Chem. 462: 235-250
29. Bouchard G., Carrupt P. A., Testa B., Gobry V. and Girault H. H. (2001) The apparent lipophilicity of quaternary ammonium ions is influenced by Galvani potential difference, not ion-pairing: A cyclic voltammetry study. Pharm. Res. 18: 702-708
30. Hitzel L., Watt A. P. and Locker K. L. (2000) An increased throughput method for the determination of partition coefficients. Pharm. Res. 17: 1389-1395
31. Pauletti G. M. and Wunderli-Allenspach H. (1994) Partition coefficients in vitro: Artificial membranes as a standardized distribution model. Eur. J. Pharm. Sci. 1: 273-281
32. Österberg T., Svensson M. and Lundahl P. (2001) Chromatographic retention of drug molecules on immobilized liposomes prepared from egg phospholipids and from chemically pure phospholipids. Eur. J. Pharm. Sci. 12: 427-439
33. Avdeef A., Box K. J., Comer J. E. A., Hibbert C. and Tam K. Y. (1997) pH-metric logP. 10. Determination of vesicle membrane-water partition coefficients of ionizable drugs. Pharm. Res. 15: 208-214
34. Razak J. L., Cutak B. J., Larive C. K. and Lunte C. E. (2001) Correlation of the capacity factor in vesicular electrokinetic chromatography with the octanol:water partition coefficient for charged and neutral analytes. Pharm. Res. 18: 104-111
35. Taillardat-Bertschinger A., Carrupt P. A. and Testa B. (2002) The relative partitioning of neutral and ionized compounds in sodium dodecyl sulfate micelles measured by micellar electrokinetic capillary electrophoresis. Eur. J. Pharm. Sci. 15: 225-234
36. Mirrlees M. S., Moulton S. J., Murphy C. T. and Taylor P. J. (1976) Direct measurement of octanol-water partiton coefficients by high-pressure liquid chromatography. J. Med. Chem. 19: 615-619
37. Unger S. H., Cook J. R. and Hollenberg J. S. (1978) Simple procedure for determining octanol-aqueous partition, distribution, and ionization coefficients by reverse-phase high-pressure liquid chromatography. J. Pharm. Sci. 67: 1364-1366
38. Pagliara A., Khamis E., Trinh A., Carrupt P.A., Tsai R. S. and Testa B. (1995) Structural properties governing retention mechanisms on RP-HPLC stationary phases used for lipophilicity measurements. J. Liquid Chromatogr. 18: 1721-1745
39. Valkó K. (2001) Measurements of physical properties for drug design in industry. In: Separation Methods in Drug Synthesis and Purification, pp. 535-583, Valkó K. (ed.), Elsevier, Amsterdam
40. Lombardo F., Shalaeva M. Y., Tupper K. A., Goa F. and Abraham M. H. (2000) ElogPoct: A tool for lipophilicity determination in drug discoovery. J. Med. Chem. 43: 2922-2928
41. Lombardo F., Shalaeva M. Y., Tupper K. A., Goa F. and Abraham M. H. (2001) ElogPoct: A tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. J. Med. Chem. 44: 2490-2497
42. Pidgeon C. and Venkataram U. V. (1989) Immobilized artificial membrane chromatography: Supports composed of membrane lipids. Anal. Biochem. 176: 36-47
43. Yang C. Y., Cai S. J., Liu H. and Pidgeon C. (1997) Immobilized artificial membranes - Screens for drug-membrane interactions. Adv. Drug Deliv. Rev. 23: 229-256
44. Avdeef A. (2001) High-throughput measurements of solubility profiles. In: Pharmacokinetic Optimization in Drug Research - Biological, Physicochemical, and Computational Strategies, pp. 305-326, Testa B., Waterbeemd H. van de, Folkers G. and Guy R. (eds), Wiley-VHCA, Zürich
45. Lipinski C. A., Lombardo F., Dominy B. W. and Feeney P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23: 3-25
46. Pan L., Ho Q., Tsutsui K. and Takahashi L. (2001) Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. J. Pharm. Sci. 90: 521-529
47. Hayward M. J., Hargiss L. O., Munson J. L., Mandiyan S. P. and Wennogle L. P. (2000) Validation of solubility measurements using ultra-filtration liquid chromatography mass spectrometry (UF-LC/MS) in Am. Soc. Mass Spec. 48th Annual Conference on Mass Spectrometry and Allied Topics, Long Beach, CA, USA, 11-15 June, p. 3
48. Kerns E. H. (2001) High throughput physicochemical profiling for drug discovery. J. Pharm. Sci. 90: 1838-1858
49. Avdeef A. and Berger C. M. (2001) pH-Metric solubility. 3. Dissolution titration template method for solubility determination. Eur. J. Pharm. Sci. 14: 271-280
50. Faller B. and Wohnsland F. (2001) Physicochemical parameters as tools in drug discovery and lead optimization. In: Pharmacokinetic Optimization in Drug Research - Biological, Physicochemical, and Computational Strategies, pp. 257-274, Testa B., Waterbeemd H. van de, Folkers G. and Guy R. (eds), Wiley-VHCA, Zürich
51. FDA Guidance for Industry Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Containing Certain Active Moieties/Active Ingredients Based on a Biopharmaceutics Classification System. CDERGUID\2062dft.wpd Draft, Jan. 1999
52. Mueller P., Rudin D. O., Tien H. T. and Westcott W. C. (1962) Reconstitution of cell membrane structure in vitro and its transformation into an excitable system. Nature 194: 979-980
53. Gutknecht J. and Tosteson D. C. (1973) Diffusion of weak acids across lipid membranes: effects of chemical reactions in the unstirred layers. Science 182: 1258-1261
54. Xiang T.-X. and Anderson B. D. (1994) Substituent contributions to the transport of substituted p-toluic acids across lipid bilayer membranes. J. Pharm. Sci. 83: 1511-1518
55. Kansy M., Senner F. and Gubernator K. (1998) Physicochemical high throughput screening: Parallel artificial membrane permeability assay in the description of passive absorption processes. J. Med. Chem. 41: 1007-1010
56. Wohnsland F. and Faller B. (2001) High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. J. Med. Chem. 44: 923-930
57. Avdeef A., Stratford M., Block E., Balogh M. P., Chambliss W. and Khan I. (2001) Drug absorption in vitro model: Filter-immobilized artificial membranes. 2. Studies of the permeability properties of lactones in Piper methysticum Forst. Eur. J. Pharm. Sci. 14: 271-280
58. Sugano K., Hamada H., Machida M., Ushio H., Saitoh K. and Terada K. (2001) Optimized conditions of bio-mimetic artificial membrane permeation assay. Int. J. Pharm. 228: 181-188
59. Testa B. (2001) Pharmacokinetic lead optimization: Fine art vs. blind technology. In: Pharmacokinetic Optimization in Drug Research - Biological, Physicochemical, and Computational Strategies, pp. 615-625, Testa B., Waterbeemd H. van de, Folkers G. and Guy R. (eds), Wiley-VHCA, Zürich